Biolumpivaxin
In February 2025, Biovet (Bharat Biotech’s animal health arm) received approval from the Central Drug Standards Control Organization (CDSCO) for Biolumpivaxin, a vaccine for Lumpy Skin Disease (LSD) in cattle and buffaloes, caused by lumpy skin disease virus (LSDV) of genus Capripoxvirus belonging to the family Poxviridae.
- It is world’s first DIVA vaccine (Differentiating Infected from Vaccinated Animals).
- It is single annual dose for cattle/buffaloes aged 3+ months.
- Developed using LSD virus/Ranchi/2019 strain (from ICAR-National Research Centre on Equines, Hisar).
- Jointly developed by Indian Council of Agricultural Research (ICAR) and Biovet.
What is DIVA Technology?
- Uses marker antigens missing in natural infection.
- Enables accurate detection, ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 MFN Clause
- 2 PM Gati-Shakti National Master Plan
- 3 Direct Benefit Transfer (DBT)
- 4 Rural Non-Farm Economy
- 5 GDP Base Year Revision
- 6 Tourism Sector in India
- 7 Primary Agricultural Credit Societies (PACS)
- 8 Human Development Report 2023-24
- 9 State of the World’s Forests 2024 Report
- 10 Uttar Poorva Transformative Industrialization Scheme, 2024
Current Affairs
- 1 Waqf (Amendment) Bill, 2024
- 2 Conserving India’s Manuscript Heritage: Gyan Bharatam Mission
- 3 Social Media Algorithmic Radicalization
- 4 Three Language Formula
- 5 Report on Swachh Bharat Mission - Grameen
- 6 Right to Access to Justice is not Absolute
- 7 Draft Digital Personal Data Protection (DPDP) Rules, 2025
- 8 Annual Ground Water Quality Report
- 9 Bharatiya Vayuyan Adhiniyam 2024
- 10 Female Labour Force Participation Rate (LFPR) in India